Persistent Asset Partners’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
Persistent Asset Partners's JANX Position: Q3 2026 in Review
Persistent Asset Partners opened a new position in Janux Therapeutics (JANX) in Q3 2026: 25,745 shares worth $445K. The stake represents 0.12% of the portfolio and ranks #119 among its holdings.
204 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- Persistent Asset Partners held 25,745 shares of Janux Therapeutics worth $445K as of Q3 2026.
- Janux Therapeutics was a new Persistent Asset Partners position in Q3 2026.
- Janux Therapeutics made up 0.12% of Persistent Asset Partners's portfolio in Q3 2026, its #119 holding.
- 204 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.